Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.233 USD | -1.36% | +4.49% | -34.41% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.5M | Capitalization | 81.23M |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | -120M | EV / Sales 2024 * | - |
Net cash position 2024 * | 37.38M | Net cash position 2025 * | 266M | EV / Sales 2025 * | -123 x |
P/E ratio 2024 * |
-0.88
x | P/E ratio 2025 * |
-0.95
x | Employees | 70 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.77% |
Latest transcript on IO Biotech, Inc.
1 day | -1.36% | ||
1 week | +4.49% | ||
Current month | +4.49% | ||
1 month | -17.80% | ||
3 months | -32.25% | ||
6 months | -2.91% | ||
Current year | -34.41% |
Managers | Title | Age | Since |
---|---|---|---|
Mai-Britt Zocca
FOU | Founder | 56 | 14-11-30 |
Amy Sullivan
DFI | Director of Finance/CFO | 54 | 22-10-14 |
Eric Faulkner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Smith
BRD | Director/Board Member | 64 | 22-02-28 |
K. Hirth
CHM | Chairman | 72 | 16-08-31 |
Kathleen Glaub
BRD | Director/Board Member | 70 | 18-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.233 | -1.36% | 153,047 |
24-06-06 | 1.25 | +3.31% | 224,829 |
24-06-05 | 1.21 | +0.83% | 124,865 |
24-06-04 | 1.2 | -1.64% | 101,385 |
24-06-03 | 1.22 | +3.39% | 83,984 |
Delayed Quote Nasdaq, June 07, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.41% | 81.23M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- IOBT Stock